Reports

From neuroscience to evidence-based psychological treatments
In March 2016 ECNP held a special meeting designed to build bridges between different constituencies of mental illness treatment researchers from a range of backgrounds with a specific focus on enhancing the development of novel, evidence-based, psychological treatments. In particular we wished to explore the potential for basic neuroscience to support the development of more effective psychological treatments, just as this approach is starting to illuminate the actions of drugs. To fulfil this aim, 100 clinical psychologists, psychiatrists and neuroscientists were brought together to address the proposition that while we know how certain psychological treatments work, we have only an approximate understanding of why they work. If a coherent mental health science is be developed therefore, the mechanisms (at all levels of analysis) of effective psychological treatments have to be uncovered. The report presents the meetings conclusions.

To read the report, click here.

Neuropsychopharmacology across Brain Diseases 
Psychiatry and neurology are two specialisms that focus on disorders of the same organ system – the brain – but from two different perspectives, which sometimes seem to be in conflict or opposition. In order to work towards a more integrated approach where each disciplines understandings could help to inform the other, the ECNP hosted a special scientific meeting with experts across a range of different disease states and including preclinical scientists as well. The report sums up the key elements of this meeting and looks to how the disciplines may work together better in future to the benefit of science and patients. 

To read the report, click here

The Size and Burden of Mental Disorders in Europe 
The ECNP/EBC ‘Size and Burden of Mental Disorders in Europe’ report, released at the 24th ECNP Congress in Paris, France, updates and expands the 2005 report. The report is the output of a three-year multi-dimensional project to quantify the scale and impact of mental illness in Europe.

To read the report, click here.

ECNP Summit Report
The Report of the 2011 Summit on the future of CNS drug research in Europe, prepared by David Nutt and Guy Goodwin, is now available.
Published in European Neuropsychopharmacology, the report summarises the output of this key gathering of European neuroscience stakeholders and offers a plan of action for how the funding crisis facing CNS drug research in Europe can be addressed.

To read the report, click here.